336 results
Page 3 of 17
6-K
EX-99.1
1ccq7vz efrqrkney
27 Feb 15
Live Filing
12:00am
6-K
EX-99.1
r7hmt70qabc186
25 Feb 15
Live Filing
12:00am
6-K
EX-99.1
t99ntp8zxmzhw 9mj0p
24 Feb 15
TEVA ANNOUNCES POSITIVE RESULTS FOR TEV-48125 IN PHASE IIb CHRONIC MIGRAINE STUDY MEETING PRIMARY AND SECONDARY ENDPOINTS
12:00am
6-K
EX-99.1
sohxvp
23 Feb 15
Live Filing
12:00am
6-K
EX-99.1
nuiwf4s
20 Feb 15
Teva to Present New Respiratory Data at 2015 Annual Meeting of the American Academy of Allergy, Asthma and Immunology
12:00am
6-K
EX-99.1
5psdw6c dt
5 Feb 15
Teva Reports Fourth Quarter and Full Year 2014 Results
12:00am
6-K
EX-99.1
nhwjfvs9
5 Feb 15
Live Filing
12:00am
6-K
EX-99.1
n91adjxw9o
26 Jan 15
Teva Receives Fda Approval for First Generic Nexium® Delayed-release Capsules In the United States
12:00am
6-K
EX-99.1
viiwz
20 Jan 15
Teva Announces U.S. Supreme Court Decision to Reverse Federal Circuit Court’s Judgment on COPAXONE®20 mg/mL Case and Remand for Further Review
12:00am
6-K
EX-99.1
5abd4nzs3zv4nf
7 Jan 15
Teva Launches Generic Diovan® In the United States
12:00am
6-K
EX-99.1
uzr3hz5yp9br nxm
23 Dec 14
Live Filing
12:00am
6-K
EX-99.1
9lrn7b2
19 Dec 14
First Waterless Nasal Allergy Spray Approved for Children as Young as Four Years of Age
12:00am
6-K
EX-99.1
m0qoj 0d3zlkvnlr
11 Dec 14
Teva Announces Launch of First Generic Celebrex® Capsules In the United States
12:00am
6-K
EX-99.1
si0kgrq55w8vd1zqe
11 Dec 14
Teva Provides 2015 Business Outlook
12:00am
6-K
EX-99.1
6bmtk5fewy1m 0evx
4 Dec 14
Live Filing
12:00am
6-K
EX-99.1
p2tb5x6ubzg2u
1 Dec 14
Teva Announces Launch of Generic Exforge HCT® Tablets In the United States
12:00am
6-K
EX-99.1
wx8v2khfof6551
1 Dec 14
Live Filing
12:00am
6-K
EX-99.1
fmami4d
26 Nov 14
Prof. Yitzhak Peterburg Elected Chairman of Teva’s Board of Directors
12:00am
6-K
EX-99.1
demlozqx
18 Nov 14
Live Filing
12:00am